Fighting AMR Media for medical/Getty Images

How to Fight Antimicrobial Resistance

Drug-resistant microbes kill 700,000 people every year – more than three times the annual death toll from armed conflicts. A global challenge of this scale demands public-private collaboration, in which governments make up for market failures, and companies bring to bear their knowledge and experience.

ZURICH – Two weeks ago, G20 leaders committed to working together to address one of the world’s most pressing and perplexing security threats: antimicrobial resistance (AMR) – a fierce and evolving adversary against which conventional therapeutic weapons are of no use.

The threat is straightforward: bacteria and other microbes are becoming resistant to available medicines faster than new medicines are being developed. Every year, drug-resistant microbes kill about 700,000 people worldwide – more than three times the annual death toll from armed conflicts.

In 2016, a special panel commissioned by the British government predicted that, by 2050, as many as ten million more people will die from drug-resistant microbes every year. AMR now poses a clear and present danger to every person on the planet. Unless we confront it head-on, we could return to a world in which it is common for people to die from basic infections.

We hope you're enjoying Project Syndicate.

To continue reading, subscribe now.

Subscribe

Get unlimited access to PS premium content, including in-depth commentaries, book reviews, exclusive interviews, On Point, the Big Picture, the PS Archive, and our annual year-ahead magazine.

http://prosyn.org/lOBQ3p2;

Cookies and Privacy

We use cookies to improve your experience on our website. To find out more, read our updated cookie policy and privacy policy.